From PsychonautWiki
Jump to navigation Jump to search

Omberacetam is the nonproprietary name proposed for Noopept (see p.68, Strictly speaking it does not belong to the racetam class of compounds (as it is a peptide). However, given its similarity it is often compared and categorized adjacent to other racetams.

On a purely pragmatic basis, I suggest we consider migrating Noopept to the racetam section. The INN may supplant the brand name in future but it's more important we set a standard in terms of naming conventions.

Update: PubChem now refers to Noopept as Omberacetam [ ] Please see above regarding INN and re-categorizing Noopept into the racetam family on a pragmatic basis. -- (unsigned) Mydriasis, 14 January - 13 October 2018‎

@Mydriasis: Done. I'll rename the article as well to reflect this change. Thanks for keeping us up to date! --Clarity (talk) 20:58, 23 October 2018 (CEST)
We still haven't get the drug class changed yet. While omberacetam is not technically a 2-pyrrolidone because the C=O bond just ain't there, it's developed to be an analogue for one, so I think it deserves a double class designation like "peptide; racetam analogue". --Artoria2e5 (talk) 08:46, 15 September 2022 (UTC)

UK Legal Status

Omberacetam is not illegal to produce/supply/import in the United Kingdom. Legality is of that similar to other countries, where it cannot be sold for human use.